Cargando…

Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities

BACKGROUND: Despite early diagnosis and treatment, Classical Galactosemia (CG) patients frequently develop long-term complications, such as cognitive impairment. Available literature primarily reports on general intellectual abilities and shows a substantially lower Full Scale Intelligence Quotient...

Descripción completa

Detalles Bibliográficos
Autores principales: Welsink-Karssies, Mendy M., Oostrom, Kim J., Hermans, Merel E., Hollak, Carla E. M., Janssen, Mirian C. H., Langendonk, Janneke G., Oussoren, Esmee, Rubio Gozalbo, M. Estela, de Vries, Maaike, Geurtsen, Gert J., Bosch, Annet M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007688/
https://www.ncbi.nlm.nih.gov/pubmed/32033562
http://dx.doi.org/10.1186/s13023-019-1277-0
_version_ 1783495357516218368
author Welsink-Karssies, Mendy M.
Oostrom, Kim J.
Hermans, Merel E.
Hollak, Carla E. M.
Janssen, Mirian C. H.
Langendonk, Janneke G.
Oussoren, Esmee
Rubio Gozalbo, M. Estela
de Vries, Maaike
Geurtsen, Gert J.
Bosch, Annet M.
author_facet Welsink-Karssies, Mendy M.
Oostrom, Kim J.
Hermans, Merel E.
Hollak, Carla E. M.
Janssen, Mirian C. H.
Langendonk, Janneke G.
Oussoren, Esmee
Rubio Gozalbo, M. Estela
de Vries, Maaike
Geurtsen, Gert J.
Bosch, Annet M.
author_sort Welsink-Karssies, Mendy M.
collection PubMed
description BACKGROUND: Despite early diagnosis and treatment, Classical Galactosemia (CG) patients frequently develop long-term complications, such as cognitive impairment. Available literature primarily reports on general intellectual abilities and shows a substantially lower Full Scale Intelligence Quotient (FSIQ) in CG patients than in the general population. Both problems in social functioning as well as internalizing problems are often reported in CG patients. The combination of intelligence, cognitive functioning, behavior and social functioning has not been studied systematically in CG patients. METHODS: To determine if CG patients demonstrate a specific neuropsychological and psychosocial profile, we investigated intelligence, functioning on multiple cognitive domains, behavior and social functioning with a comprehensive neuropsychological test battery and questionnaires (self- and proxy-reported). RESULTS: The data of 48 patients, aged 4–47 years are reported. FSIQ ranged from 45 to 103 (mean 77 ± 14). A negative correlation between age and FSIQ was demonstrated (p = 0.037) which resulted directly from the inclusion of four young ‘milder’ patients detected by newborn screening (NBS) with an expected better clinical outcome. Compared to normative data, patients had significantly lower but highly variable scores on all cognitive domains, especially on tests requiring mental speed. In the context of the FSIQ, 43% of the cognitive test results exceeded IQ based expectations. Overall, the patients’ scores on social functioning were in the normal range but internalizing problems were frequently reported. In our cohort, an early initiation of dietary treatment due to NBS or family screening did not result in a more favorable neuropsychological outcome. CONCLUSIONS: In this study, we demonstrated that as a cohort, CG patients have a below average intelligence and impaired cognitive functioning without a distinctive neuropsychological profile. The effect of age on neurocognitive functioning should be assessed in longitudinal studies. Social functioning was not impaired, but patients may be at risk for internalizing problems. Considering the large variability in cognitive, behavioral and social functioning and the finding that cognitive outcomes may exceed IQ based expectations, an individual evaluation and follow-up is warranted in all CG patients to ensure timely support if needed.
format Online
Article
Text
id pubmed-7007688
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70076882020-02-13 Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities Welsink-Karssies, Mendy M. Oostrom, Kim J. Hermans, Merel E. Hollak, Carla E. M. Janssen, Mirian C. H. Langendonk, Janneke G. Oussoren, Esmee Rubio Gozalbo, M. Estela de Vries, Maaike Geurtsen, Gert J. Bosch, Annet M. Orphanet J Rare Dis Research BACKGROUND: Despite early diagnosis and treatment, Classical Galactosemia (CG) patients frequently develop long-term complications, such as cognitive impairment. Available literature primarily reports on general intellectual abilities and shows a substantially lower Full Scale Intelligence Quotient (FSIQ) in CG patients than in the general population. Both problems in social functioning as well as internalizing problems are often reported in CG patients. The combination of intelligence, cognitive functioning, behavior and social functioning has not been studied systematically in CG patients. METHODS: To determine if CG patients demonstrate a specific neuropsychological and psychosocial profile, we investigated intelligence, functioning on multiple cognitive domains, behavior and social functioning with a comprehensive neuropsychological test battery and questionnaires (self- and proxy-reported). RESULTS: The data of 48 patients, aged 4–47 years are reported. FSIQ ranged from 45 to 103 (mean 77 ± 14). A negative correlation between age and FSIQ was demonstrated (p = 0.037) which resulted directly from the inclusion of four young ‘milder’ patients detected by newborn screening (NBS) with an expected better clinical outcome. Compared to normative data, patients had significantly lower but highly variable scores on all cognitive domains, especially on tests requiring mental speed. In the context of the FSIQ, 43% of the cognitive test results exceeded IQ based expectations. Overall, the patients’ scores on social functioning were in the normal range but internalizing problems were frequently reported. In our cohort, an early initiation of dietary treatment due to NBS or family screening did not result in a more favorable neuropsychological outcome. CONCLUSIONS: In this study, we demonstrated that as a cohort, CG patients have a below average intelligence and impaired cognitive functioning without a distinctive neuropsychological profile. The effect of age on neurocognitive functioning should be assessed in longitudinal studies. Social functioning was not impaired, but patients may be at risk for internalizing problems. Considering the large variability in cognitive, behavioral and social functioning and the finding that cognitive outcomes may exceed IQ based expectations, an individual evaluation and follow-up is warranted in all CG patients to ensure timely support if needed. BioMed Central 2020-02-07 /pmc/articles/PMC7007688/ /pubmed/32033562 http://dx.doi.org/10.1186/s13023-019-1277-0 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Welsink-Karssies, Mendy M.
Oostrom, Kim J.
Hermans, Merel E.
Hollak, Carla E. M.
Janssen, Mirian C. H.
Langendonk, Janneke G.
Oussoren, Esmee
Rubio Gozalbo, M. Estela
de Vries, Maaike
Geurtsen, Gert J.
Bosch, Annet M.
Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities
title Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities
title_full Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities
title_fullStr Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities
title_full_unstemmed Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities
title_short Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities
title_sort classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007688/
https://www.ncbi.nlm.nih.gov/pubmed/32033562
http://dx.doi.org/10.1186/s13023-019-1277-0
work_keys_str_mv AT welsinkkarssiesmendym classicalgalactosemianeuropsychologicalandpsychosocialfunctioningbeyondintellectualabilities
AT oostromkimj classicalgalactosemianeuropsychologicalandpsychosocialfunctioningbeyondintellectualabilities
AT hermansmerele classicalgalactosemianeuropsychologicalandpsychosocialfunctioningbeyondintellectualabilities
AT hollakcarlaem classicalgalactosemianeuropsychologicalandpsychosocialfunctioningbeyondintellectualabilities
AT janssenmirianch classicalgalactosemianeuropsychologicalandpsychosocialfunctioningbeyondintellectualabilities
AT langendonkjannekeg classicalgalactosemianeuropsychologicalandpsychosocialfunctioningbeyondintellectualabilities
AT oussorenesmee classicalgalactosemianeuropsychologicalandpsychosocialfunctioningbeyondintellectualabilities
AT rubiogozalbomestela classicalgalactosemianeuropsychologicalandpsychosocialfunctioningbeyondintellectualabilities
AT devriesmaaike classicalgalactosemianeuropsychologicalandpsychosocialfunctioningbeyondintellectualabilities
AT geurtsengertj classicalgalactosemianeuropsychologicalandpsychosocialfunctioningbeyondintellectualabilities
AT boschannetm classicalgalactosemianeuropsychologicalandpsychosocialfunctioningbeyondintellectualabilities